Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section now lists Colorado, Michigan, Texas, and Washington as study sites, and the page revision is updated to v3.3.3. The HHS Vulnerability Disclosure link and the prior state location entries were removed in this update.SummaryDifference0.6%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor UI/backend change with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedA site-wide notice about government funding and operating status has been removed from the page. This does not affect the study details or primary content on the ClinicalTrials.gov record; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe new screenshot shows minor styling and layout adjustments to the Study Details page with no changes to core content such as the study title, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference6%

- Check97 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.